Fine Mark National Bank & Trust Kala Pharmaceuticals, Inc. Transaction History

Fine Mark National Bank & Trust

  • $2.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$0.61 - $1.84 $6,100 - $18,400
10,000 New
10,000 $14,000
Q4 2021

Feb 14, 2022
SELL
$1.16 - $2.74 $11,600 - $27,400
-10,000 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$6.28 - $8.79 $62,800 - $87,899
10,000 New
10,000 $68,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $7.83M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email